The Clinical Translational Research Award is intended to support correlative studies that are associated with a clinical trial. The translational research should address high-impact or unmet needs in ovarian cancer. Applications focused on the following OCRP priority are encouraged to apply:
• Utilize precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomes
Although not intended to fund the operational aspects of clinical trials, this award supports research projects related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. Projects that develop clinical endpoints for clinical trials are also encouraged. The application must demonstrate availability and accessibility of the appropriate human subject population, specimens, or human-based resources. The application should also provide a detailed statistical analysis plan that includes a power analysis reflecting sample size projections that will allow a meaningful outcome. Preclinical studies in animals are not allowed.
Deadlines:
• Required Pre-Application Deadline: April 1, 2021
• Invitation to Submit an Application: May 2021
• Application Submission Deadline: July 8, 2021
The Principal Investigator (PI) must be at or above the level of Assistant Professor (or equivalent) to be eligible to submit an application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.
The anticipated direct costs budgeted for the entire period of performance for an FY21 OCRP Clinical Translational Research Award will not exceed $450,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
